Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. The company is headquartered in Washington, Washington Dc and currently employs 61,000 full-time employees. The firm operates through three segments: Biotechnology, Life Sciences and Diagnostics. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a broad range of equipment, consumables and services that are primarily used by customers to advance and accelerate the research, development, manufacture and delivery of biological medicines. The Life Sciences segment offers a broad range of instruments, consumables, services and software that are primarily used by customers to study the basic building blocks of life, including deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), nucleic acid, proteins, metabolites and cells. The Diagnostics segment offers clinical instruments, consumables, software and services that hospitals, physicians’ offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions.
Follow-Up Questions
Danaher Corp (DHR)의 PER은 얼마입니까?
Danaher Corp의 PER은 37.9513입니다
Danaher Corp의 CEO는 누구입니까?
Mr. Rainer Blair은 2014부터 회사에 합류한 Danaher Corp의 President입니다.
DHR 주식의 가격 성능은 어떻습니까?
DHR의 현재 가격은 $214.31이며, 전 거래일에 increased 0.22% 하였습니다.
Danaher Corp의 주요 사업 주제나 업종은 무엇입니까?
Danaher Corp은 Life Sciences Tools & Services 업종에 속하며, 해당 부문은 Health Care입니다
Danaher Corp의 시가총액은 얼마입니까?
Danaher Corp의 현재 시가총액은 $153.4B입니다
Danaher Corp는 매수, 매도, 아니면 보유해야 하나요?
월스트리트 분석가들에 따르면, 23명의 분석가가 Danaher Corp에 대한 분석 평가를 실시했으며, 이는 12명의 강력한 매수, 15명의 매수, 3명의 보유, 0명의 매도, 그리고 12명의 강력한 매도를 포함합니다